Emily Kaiser


Brolucizumab shows evidence of retinal drying in wet AMD

December 15, 2021

Jill Hopkins, MD, discusses results from phase 3a of the Merlin trial for brolucizumab as a treatment for wet AMD and provides updates on KESTREL and KITE trials for the treatment of diabetic macular edema.